Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)

Hangzhou Biotest Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,864	3,452	3,229	4,928	7,456	-
Market Cap Growth	48.09%	6.92%	-34.48%	-33.91%	-	-
Enterprise Value	3,239	1,845	1,370	2,774	5,736	-
Last Close Price	33.24	22.73	20.21	28.71	41.65	-
PE Ratio	35.76	20.36	30.29	6.37	8.94	-
PS Ratio	9.51	6.17	7.30	2.59	4.10	-
PB Ratio	2.01	1.43	1.33	1.92	3.54	-
P/TBV Ratio	2.26	1.62	1.46	2.10	3.57	-
P/FCF Ratio	373.11	-	43.08	9.40	10.53	-
P/OCF Ratio	48.70	26.80	24.58	7.01	8.21	-
EV/Sales Ratio	6.33	3.30	3.10	1.46	3.16	-
EV/EBITDA Ratio	30.72	13.77	47.44	3.59	5.92	-
EV/EBIT Ratio	38.71	16.36	325.74	3.69	5.97	-
EV/FCF Ratio	248.48	-	18.28	5.29	8.10	-
Debt / Equity Ratio	0	0	0.00	0.00	0.01	0.03
Debt / EBITDA Ratio	0.01	0.00	0.09	0.01	0.01	0.02
Debt / FCF Ratio	0.08	-	0.04	0.02	0.02	0.03
Asset Turnover	0.20	0.22	0.17	0.73	1.19	2.05
Inventory Turnover	3.31	3.32	2.30	6.79	6.03	3.77
Quick Ratio	15.60	9.81	13.27	12.16	5.93	1.93
Current Ratio	16.74	10.51	13.97	13.07	6.40	2.46
Return on Equity (ROE)	5.57%	6.90%	4.23%	33.13%	65.52%	152.90%
Return on Assets (ROA)	2.04%	2.72%	0.10%	18.15%	39.19%	77.90%
Return on Capital (ROIC)	2.16%	2.91%	0.10%	20.06%	46.66%	107.44%
Return on Capital Employed (ROCE)	3.40%	4.70%	0.20%	29.20%	45.50%	118.70%
Earnings Yield	2.85%	4.91%	3.30%	15.70%	11.18%	-
FCF Yield	0.27%	-3.37%	2.32%	10.64%	9.50%	-
Dividend Yield	3.25%	4.71%	2.83%	5.47%	5.15%	-
Payout Ratio	98.73%	49.34%	220.13%	41.37%	2.51%	23.07%
Buyback Yield / Dilution	-0.83%	1.23%	0.10%	-23.14%	-8.33%	0.01%
Total Shareholder Return	2.37%	5.95%	2.93%	-17.67%	-3.18%	0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.